486
Participants
Start Date
March 31, 2010
Primary Completion Date
January 31, 2011
Study Completion Date
January 31, 2011
N1539
5 mg IV once per day
N1539
7.5 mg IV once per day
N1539
15 mg IV once per day
N1539
30 mg IV once per day
placebo
IV placebo once per day
Morphine
morphine 10-15 mg IV once per day
N1539
60 mg IV once per day
Belgrade
Novi Sad
Kragujevac
Tbilisi
Tbilisi
Bialystok
Gdansk
Lodz
Lublin
Poznan
Ruda Śląska
Szczecin
Lead Sponsor
Alkermes, Inc.
INDUSTRY